Literature DB >> 15240602

Relationship between follicle-stimulating hormone levels at the beginning of the human menstrual cycle, length of the follicular phase and excreted estrogens: the FREEDOM study.

F Miro1, S W Parker, L J Aspinall, J Coley, P W Perry, J E Ellis.   

Abstract

Although reproductive aging has been separately related to elevated FSH and shorter follicular phase (FP), the direct association between both parameters has not been investigated. Also, the exact effects of increased FSH on estrogen production are yet to be established.A large database of daily urinary concentrations of FSH, LH, and estrone 3-glucuronide (E1G) from 37 regularly menstruating women (median 11 cycles per patient) was used. Initial FSH levels (iFSH) were estimated as the mean value of d 1-5. The day of E1G take-off (ETO) was determined by an algorithm, and accordingly, the FP was divided into early (d 1 to ETO) and late (ETO+1 to LH peak). FP maximum and integrated E1G were calculated. Subjects were distributed according to their mean iFSH into three categories (</=5, >5 to 10, and >10 IU/liter). There was a gradual decrease in FP length with increasing category (15.2 +/- 3.8, 14.1 +/- 3.6, and 13 +/- 2.6 d, respectively; P < 0.0001). A similar effect occurred in early FP (7.5 +/- 4, 6.4 +/- 3.7, and 5.4 +/- 2.7; P < 0.0001); in contrast, late FP was unaffected (7.7 +/- 2.1, 7.7 +/- 2.1, and 7.6 +/- 2.4; P = 0.86). No consistent increase in E1G was found with advancing iFSH category; however, women with mean initial LH higher than 6 IU/liter had significantly elevated maximum (P < 0.0001) and integrated (P = 0.002) E1G.FP length decreases in parallel with increasing iFSH, with a selective effect on the early FP. Increased FSH does not affect E1G; however, elevated initial LH level was related to higher E1G.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15240602     DOI: 10.1210/jc.2003-031732

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

Review 1.  Ovarian aging and the perimenopausal transition: the paradox of endogenous ovarian hyperstimulation.

Authors:  Jerilynn C Prior
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

2.  Urinary beta-luteinizing hormone and beta-follicle stimulating hormone immunoenzymometric assays for population research.

Authors:  Eleanor Brindle; Rebecca C Miller; Jane B Shofer; Nancy A Klein; Michael R Soules; Kathleen A O'Connor
Journal:  Clin Biochem       Date:  2006-09-01       Impact factor: 3.281

Review 3.  Sex hormones and mood in the perimenopause.

Authors:  Peter J Schmidt; David R Rubinow
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

4.  Hypoestrogenic "inactive phases" at the start of the menstrual cycle: changes with age and reproductive stage, and relationship to follicular depletion.

Authors:  Rebecca J Ferrell; Germán Rodríguez; Darryl Holman; Kathleen O'Connor; James W Wood; Maxine Weinstein
Journal:  Fertil Steril       Date:  2012-08-14       Impact factor: 7.329

Review 5.  Reproductive aging, sex steroids, and mood disorders.

Authors:  Veronica Harsh; Samantha Meltzer-Brody; David R Rubinow; Peter J Schmidt
Journal:  Harv Rev Psychiatry       Date:  2009       Impact factor: 3.732

Review 6.  Migraine headache in perimenopausal and menopausal women.

Authors:  E Anne MacGregor
Journal:  Curr Pain Headache Rep       Date:  2009-10

7.  Population correlations do not support the existence of set points for blood levels of calcium or glucose - a new model for homeostasis.

Authors:  Stephen P Fitzgerald; Nigel G Bean
Journal:  Physiol Rep       Date:  2018-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.